(2S,5S)-2-tert-butyl-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-2-(2-methoxypropan-2-yl)-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-2-(4-methyloxan-4-yl)-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-propan-2-ylpentanamide;(2R,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-(trifluoromethyl)pentanamide

C138H191F3N20O17S5 — CID 158648188

IUPAC(2S,5S)-2-tert-butyl-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-2-(2-methoxypropan-2-yl)-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-2-(4-methyloxan-4-yl)-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-propan-2-ylpentanamide;(2R,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-(trifluoromethyl)pentanamide
SMILESCC[C@@H](C)C(=O)N[C@H](C(=O)C[C@H](C(=O)Nc1snnc1-c1ccccc1)C(C)(C)C)C1CCCCC1.CC[C@@H](C)C(=O)N[C@H](C(=O)C[C@H](C(=O)Nc1snnc1-c1ccccc1)C(C)(C)OC)C1CCCCC1.CC[C@@H](C)C(=O)N[C@H](C(=O)C[C@H](C(=O)Nc1snnc1-c1ccccc1)C(C)C)C1CCCCC1.CC[C@@H](C)C(=O)N[C@H](C(=O)C[C@H](C(=O)Nc1snnc1-c1ccccc1)C(F)(F)F)C1CCCCC1.CC[C@@H](C)C(=O)N[C@H](C(=O)C[C@H](C(=O)Nc1snnc1-c1ccccc1)C1(C)CCOCC1)C1CCCCC1
InChIInChI=1S/C30H42N4O4S.C28H40N4O4S.C28H40N4O3S.C27H38N4O3S.C25H31F3N4O3S/c1-4-20(2)27(36)31-25(21-11-7-5-8-12-21)24(35)19-23(30(3)15-17-38-18-16-30)28(37)32-29-26(33-34-39-29)22-13-9-6-10-14-22;1-6-18(2)25(34)29-23(19-13-9-7-10-14-19)22(33)17-21(28(3,4)36-5)26(35)30-27-24(31-32-37-27)20-15-11-8-12-16-20;1-6-18(2)25(34)29-23(19-13-9-7-10-14-19)22(33)17-21(28(3,4)5)26(35)30-27-24(31-32-36-27)20-15-11-8-12-16-20;1-5-18(4)25(33)28-23(19-12-8-6-9-13-19)22(32)16-21(17(2)3)26(34)29-27-24(30-31-35-27)20-14-10-7-11-15-20;1-3-15(2)22(34)29-20(16-10-6-4-7-11-16)19(33)14-18(25(26,27)28)23(35)30-24-21(31-32-36-24)17-12-8-5-9-13-17/h6,9-10,13-14,20-21,23,25H,4-5,7-8,11-12,15-19H2,1-3H3,(H,31,36)(H,32,37);8,11-12,15-16,18-19,21,23H,6-7,9-10,13-14,17H2,1-5H3,(H,29,34)(H,30,35);8,11-12,15-16,18-19,21,23H,6-7,9-10,13-14,17H2,1-5H3,(H,29,34)(H,30,35);7,10-11,14-15,17-19,21,23H,5-6,8-9,12-13,16H2,1-4H3,(H,28,33)(H,29,34);5,8-9,12-13,15-16,18,20H,3-4,6-7,10-11,14H2,1-2H3,(H,29,34)(H,30,35)/t20-,23-,25+;2*18-,21-,23+;18-,21+,23+;15-,18-,20+/m11111/s1
InChIKeyIBFLCSJSXHZESJ-MWUZLTSHSA-N
MW2619.50 g/mol
LogP27.66
Rot. Bonds54

About (2S,5S)-2-tert-butyl-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-2-(2-methoxypropan-2-yl)-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-2-(4-methyloxan-4-yl)-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-propan-2-ylpentanamide;(2R,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-(trifluoromethyl)pentanamide

(2S,5S)-2-tert-butyl-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-2-(2-methoxypropan-2-yl)-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-2-(4-methyloxan-4-yl)-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-propan-2-ylpentanamide;(2R,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-(trifluoromethyl)pentanamide (PubChem CID 158648188) has the molecular formula C138H191F3N20O17S5 and a molecular weight of 2619.50 g/mol. Its IUPAC name is (2S,5S)-2-tert-butyl-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-2-(2-methoxypropan-2-yl)-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-2-(4-methyloxan-4-yl)-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-propan-2-ylpentanamide;(2R,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-(trifluoromethyl)pentanamide.

Molecular Properties

Compound Name(2S,5S)-2-tert-butyl-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-2-(2-methoxypropan-2-yl)-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-2-(4-methyloxan-4-yl)-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-propan-2-ylpentanamide;(2R,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-(trifluoromethyl)pentanamide
PubChem CID158648188
Molecular FormulaC138H191F3N20O17S5
Molecular Weight2619.50 g/mol
Exact Mass2617.33
IUPAC Name(2S,5S)-2-tert-butyl-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-2-(2-methoxypropan-2-yl)-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-2-(4-methyloxan-4-yl)-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-propan-2-ylpentanamide;(2R,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-(trifluoromethyl)pentanamide
SMILESCC[C@@H](C)C(=O)N[C@H](C(=O)C[C@H](C(=O)Nc1snnc1-c1ccccc1)C(C)(C)C)C1CCCCC1.CC[C@@H](C)C(=O)N[C@H](C(=O)C[C@H](C(=O)Nc1snnc1-c1ccccc1)C(C)(C)OC)C1CCCCC1.CC[C@@H](C)C(=O)N[C@H](C(=O)C[C@H](C(=O)Nc1snnc1-c1ccccc1)C(C)C)C1CCCCC1.CC[C@@H](C)C(=O)N[C@H](C(=O)C[C@H](C(=O)Nc1snnc1-c1ccccc1)C(F)(F)F)C1CCCCC1.CC[C@@H](C)C(=O)N[C@H](C(=O)C[C@H](C(=O)Nc1snnc1-c1ccccc1)C1(C)CCOCC1)C1CCCCC1
InChIInChI=1S/C30H42N4O4S.C28H40N4O4S.C28H40N4O3S.C27H38N4O3S.C25H31F3N4O3S/c1-4-20(2)27(36)31-25(21-11-7-5-8-12-21)24(35)19-23(30(3)15-17-38-18-16-30)28(37)32-29-26(33-34-39-29)22-13-9-6-10-14-22;1-6-18(2)25(34)29-23(19-13-9-7-10-14-19)22(33)17-21(28(3,4)36-5)26(35)30-27-24(31-32-37-27)20-15-11-8-12-16-20;1-6-18(2)25(34)29-23(19-13-9-7-10-14-19)22(33)17-21(28(3,4)5)26(35)30-27-24(31-32-36-27)20-15-11-8-12-16-20;1-5-18(4)25(33)28-23(19-12-8-6-9-13-19)22(32)16-21(17(2)3)26(34)29-27-24(30-31-35-27)20-14-10-7-11-15-20;1-3-15(2)22(34)29-20(16-10-6-4-7-11-16)19(33)14-18(25(26,27)28)23(35)30-24-21(31-32-36-24)17-12-8-5-9-13-17/h6,9-10,13-14,20-21,23,25H,4-5,7-8,11-12,15-19H2,1-3H3,(H,31,36)(H,32,37);8,11-12,15-16,18-19,21,23H,6-7,9-10,13-14,17H2,1-5H3,(H,29,34)(H,30,35);8,11-12,15-16,18-19,21,23H,6-7,9-10,13-14,17H2,1-5H3,(H,29,34)(H,30,35);7,10-11,14-15,17-19,21,23H,5-6,8-9,12-13,16H2,1-4H3,(H,28,33)(H,29,34);5,8-9,12-13,15-16,18,20H,3-4,6-7,10-11,14H2,1-2H3,(H,29,34)(H,30,35)/t20-,23-,25+;2*18-,21-,23+;18-,21+,23+;15-,18-,20+/m11111/s1
InChIKeyIBFLCSJSXHZESJ-MWUZLTSHSA-N
XLogP27.66
TPSA523.71 Ų
H-Bond Donors10
H-Bond Acceptors32
Rotatable Bonds54
Heavy Atoms183
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002619.50
LogP ≤ 527.66
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1032

Analyze (2S,5S)-2-tert-butyl-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-2-(2-methoxypropan-2-yl)-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-2-(4-methyloxan-4-yl)-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-propan-2-ylpentanamide;(2R,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-(trifluoromethyl)pentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2S,5S)-2-tert-butyl-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-2-(2-methoxypropan-2-yl)-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-2-(4-methyloxan-4-yl)-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-propan-2-ylpentanamide;(2R,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-(trifluoromethyl)pentanamide?
The IUPAC name of (2S,5S)-2-tert-butyl-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-2-(2-methoxypropan-2-yl)-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-2-(4-methyloxan-4-yl)-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-propan-2-ylpentanamide;(2R,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-(trifluoromethyl)pentanamide (CID 158648188) is (2S,5S)-2-tert-butyl-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-2-(2-methoxypropan-2-yl)-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-2-(4-methyloxan-4-yl)-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-propan-2-ylpentanamide;(2R,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-(trifluoromethyl)pentanamide.
What is the SMILES notation for (2S,5S)-2-tert-butyl-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-2-(2-methoxypropan-2-yl)-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-2-(4-methyloxan-4-yl)-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-propan-2-ylpentanamide;(2R,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-(trifluoromethyl)pentanamide?
The canonical SMILES for (2S,5S)-2-tert-butyl-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-2-(2-methoxypropan-2-yl)-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-2-(4-methyloxan-4-yl)-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-propan-2-ylpentanamide;(2R,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-(trifluoromethyl)pentanamide is CC[C@@H](C)C(=O)N[C@H](C(=O)C[C@H](C(=O)Nc1snnc1-c1ccccc1)C(C)(C)C)C1CCCCC1.CC[C@@H](C)C(=O)N[C@H](C(=O)C[C@H](C(=O)Nc1snnc1-c1ccccc1)C(C)(C)OC)C1CCCCC1.CC[C@@H](C)C(=O)N[C@H](C(=O)C[C@H](C(=O)Nc1snnc1-c1ccccc1)C(C)C)C1CCCCC1.CC[C@@H](C)C(=O)N[C@H](C(=O)C[C@H](C(=O)Nc1snnc1-c1ccccc1)C(F)(F)F)C1CCCCC1.CC[C@@H](C)C(=O)N[C@H](C(=O)C[C@H](C(=O)Nc1snnc1-c1ccccc1)C1(C)CCOCC1)C1CCCCC1.
What is the InChIKey of (2S,5S)-2-tert-butyl-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-2-(2-methoxypropan-2-yl)-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-2-(4-methyloxan-4-yl)-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-propan-2-ylpentanamide;(2R,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-(trifluoromethyl)pentanamide?
The InChIKey is IBFLCSJSXHZESJ-MWUZLTSHSA-N. The full InChI is InChI=1S/C30H42N4O4S.C28H40N4O4S.C28H40N4O3S.C27H38N4O3S.C25H31F3N4O3S/c1-4-20(2)27(36)31-25(21-11-7-5-8-12-21)24(35)19-23(30(3)15-17-38-18-16-30)28(37)32-29-26(33-34-39-29)22-13-9-6-10-14-22;1-6-18(2)25(34)29-23(19-13-9-7-10-14-19)22(33)17-21(28(3,4)36-5)26(35)30-27-24(31-32-37-27)20-15-11-8-12-16-20;1-6-18(2)25(34)29-23(19-13-9-7-10-14-19)22(33)17-21(28(3,4)5)26(35)30-27-24(31-32-36-27)20-15-11-8-12-16-20;1-5-18(4)25(33)28-23(19-12-8-6-9-13-19)22(32)16-21(17(2)3)26(34)29-27-24(30-31-35-27)20-14-10-7-11-15-20;1-3-15(2)22(34)29-20(16-10-6-4-7-11-16)19(33)14-18(25(26,27)28)23(35)30-24-21(31-32-36-24)17-12-8-5-9-13-17/h6,9-10,13-14,20-21,23,25H,4-5,7-8,11-12,15-19H2,1-3H3,(H,31,36)(H,32,37);8,11-12,15-16,18-19,21,23H,6-7,9-10,13-14,17H2,1-5H3,(H,29,34)(H,30,35);8,11-12,15-16,18-19,21,23H,6-7,9-10,13-14,17H2,1-5H3,(H,29,34)(H,30,35);7,10-11,14-15,17-19,21,23H,5-6,8-9,12-13,16H2,1-4H3,(H,28,33)(H,29,34);5,8-9,12-13,15-16,18,20H,3-4,6-7,10-11,14H2,1-2H3,(H,29,34)(H,30,35)/t20-,23-,25+;2*18-,21-,23+;18-,21+,23+;15-,18-,20+/m11111/s1.
What are the key properties of (2S,5S)-2-tert-butyl-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-2-(2-methoxypropan-2-yl)-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-2-(4-methyloxan-4-yl)-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-propan-2-ylpentanamide;(2R,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-(trifluoromethyl)pentanamide?
(2S,5S)-2-tert-butyl-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-2-(2-methoxypropan-2-yl)-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-2-(4-methyloxan-4-yl)-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-propan-2-ylpentanamide;(2R,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-(trifluoromethyl)pentanamide has a molecular weight of 2619.50 g/mol, XLogP of 27.66, 54 rotatable bonds, 10 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for (2S,5S)-2-tert-butyl-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-2-(2-methoxypropan-2-yl)-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-2-(4-methyloxan-4-yl)-4-oxo-N-(4-phenylthiadiazol-5-yl)pentanamide;(2S,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-propan-2-ylpentanamide;(2R,5S)-5-cyclohexyl-5-[[(2R)-2-methylbutanoyl]amino]-4-oxo-N-(4-phenylthiadiazol-5-yl)-2-(trifluoromethyl)pentanamide is sourced from PubChem (CID 158648188), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).